Veru Inc.的动态

查看Veru Inc.的组织主页
Veru Inc.

7,866 位关注者

https://lnkd.in/gAEpekji

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY? (Semaglutide) for Weight Reduction

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY? (Semaglutide) for Weight Reduction

ir.verupharma.com

Larry B.

Retired Investor

1 个月

Anybody know why the stock is worth half of its value from Friday considering this is supposedly good news?

赞
回复
T. Katerina Grigoriou

Fluent translator between innovative science and unmet health needs // Inquisitive Driver | Synthesizer | Catalyst

1 个月

Really exciting results! Preserving lean muscle mass with such dramatic, fast weight loss is so important for overall health. Looking forward to learning more about the side effect profile!

赞
回复
1 次回应
Richard Goldstein, MD, PhD, MHCM,FACS

CEO, Bento Biology Platforms, Inc.; Board of Directors, Senscio System, Inc.; Venture Partner / Operating Partner, Dria Ventures

1 个月

Really exciting results! Congratulations Dr Steiner and the entire Veru team. This is very significant!

赞
回复
1 次回应
查看更多评论

要查看或添加评论，请登录

Veru Inc.

7,866 位关注者